Envisagenics, a startup founded by scientists from Cold Spring Harbor Laboratory, has raised a $25 million series B round to develop drugs for cancer and …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed
SAN FRANCISCO — Surgeons should be extremely judicious in ordering fresh frozen plasma (FFP) as part of perioperative blood transfusions, suggested a nationwide analysis reported
The FDA is pausing patient enrollment and screening for Nurix Therapeutics’ Phase I clinical trial for a potential drug to treat B-cell malignancies in cancer